Positive impact on 10-year outcome of the window of opportunity for conventional synthetic DMARDs in rheumatoid arthritis: results from the ESPOIR cohort

OBJECTIVE: This study aimed to assess the impact of disease-modifying antirheumatic drugs (DMARDs) on 10-year outcomes in rheumatoid arthritis (RA). METHODS: Patients with RA from the ESPOIR cohort with complete data on Disease Activity Score in 28 Joints (DAS28) and Health Assessment Questionnaire...

Descripción completa

Detalles Bibliográficos
Autores principales: Kedra, Joanna, Lafourcade, Alexandre, Combe, Bernard, Dougados, Maxime, Hajage, David, Fautrel, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086647/
https://www.ncbi.nlm.nih.gov/pubmed/35534053
http://dx.doi.org/10.1136/rmdopen-2021-002040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086647/
https://www.ncbi.nlm.nih.gov/pubmed/35534053
http://dx.doi.org/10.1136/rmdopen-2021-002040

Ejemplares similares